Benzinga | Nov 15, 2021 11:17AM EST

Qualigen Therapeutics Q3 EPS $(0.10) Down From $0.41 YoY, Sales $1.16M Up From $1.11M YoY

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.10) per share. This is a 124.39 percent decrease over earnings of $0.41 per share from the same period last year. The company reported $1.16 million in sales this quarter. This is a 4.24 percent increase over sales of $1.11 million the same period last year.